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Abstract
Complex network approach has become an effective way to describe interrelationships among large amounts of biolog-
ical data, which is especially useful in finding core functions and global behavior of biological systems. Hypertension
is a complex disease caused by many reasons including genetic, physiological, psychological and even social factors.
In this paper, based on the information of biological pathways, we construct a network model of hypertension-related
genes of the salt-sensitive rat to explore the interrelationship between genes. Statistical and topological characteristics
show that the network has the small-world but not scale-free property, and exhibits a modular structure, revealing
compact and complex connections among these genes. By the threshold of integrated centrality larger than 0.71,
seven key hub genes are found: Jun, Rps6kb1, Cycs, Creb3l2, Cdk4, Actg1 and RT1-Da. These genes should play
an important role in hypertension, suggesting that the treatment of hypertension should focus on the combination of
drugs on multiple genes.
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1. Introduction
The study of complex systems clearly shows that the global behavior of systems is determined by their structure
rather than by the properties of their individual parts. The complex network approach has become a powerful tool for
studying complex systems, and the global properties of systems are usually studied by abstracting individual elements
of systems into nodes and reducing interactions between elements to edges between nodes [1, 2, 3, 4, 5]. Such an
approach has been widely applied to understanding gene functions in biological and medical research [6, 7, 8, 9, 10].
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Essential hypertension, which accounts for about 90%–95% of all cases of hypertension [11], is a disease caused
by long-term interaction between genetic and environmental factors, and salt is one of the important environmental
factors [12]. The blood pressure response to salt loading or salt restriction is heterogeneous among individuals, which
is known as salt sensitivity [13, 14, 15]. Salt sensitivity is the genetic susceptibility of individual blood pressure
response to salt, and is an intermediate phenotype of essential hypertension [16, 17]. The people who suffer the
salt-sensitive (SS) hypertension account for about 50% of hypertensive patients [15]. Although the clinical research
and treatment of hypertension have improved dramatically [18, 19, 20], its molecular mechanisms and pathologies
involved are still difficult to ascertain.
Many omic data have been obtained and become available through advanced high-throughput technologies, which
provide the basis for studying the relationship of biological data by network approach [7, 10]. Various biomolecular
networks have been constructed to discover essential functions and mechanisms of biological phenomena [6, 8, 9]. For
instance, Censi et al. studied the gene regulatory networks induced in heart tissue by atrial fibrillation [21]. Demicheli
and Coradini analyzed breast cancer behavior using gene regulatory networks [22]. Therefore, it is of significance to
understand hypertension disease at system level using the complex network approach.
In our previous study [23], we constructed a hypertension-related gene co-expression network by focusing on the
analysis of gene expression data (GED) [24] among the Dahl SS rat [25, 26] and two consomic rat strains [27, 28],
where the 335 nodes are individual genes and the connections are derived from the expression correlations. This is
a theoretical analysis based on GED to determine the key hub genes (nodes) and explore the relationship between
these hub genes and hypertension. However, to get more biologically relevant information about hypertension, a
pathway-based gene network should also be constructed using the actual biological correlations.
In the present work, we attempt to study the genes that are involved in SS hypertension based on the information
of biological pathways. A biological pathway is a series of actions among molecules in a cell that leads to a certain
product or a change in a cell [29, 30]. Such a pathway can trigger the assembly of new molecules or turn genes
on and off. Since biological pathways such as metabolic and signal transduction pathways can directly be viewed
as interconnected processes of molecular species in the cell [29, 30]; therefore, constructing a pathway-based gene
network could help to disentangle the actual biological interactions between genes.
In this paper, we will construct the network model of hypertension-related genes according to whether these genes
are involved in the same pathways in the KEGG1 database. Network approach will be employed to investigate the
possible relations between network structure and hypertension-related genes based on these data. Through calculating
several statistical indices and analyzing topological characteristics of the network, we find that the pathway-based
gene network exhibits the small-world but not scale-free property. Meanwhile, the network also exhibits a modular
structure: the nodes of the network can be properly divided into groups within which the nodes are highly connected,
but between which they are much less connected. The modular structure analysis can visualize the weak connections
of the network, and thus help us to study drug targets of hypertension. The results from this paper and the analysis in
Ref. [23] would complement each other.
The rest of this paper is organized as follows. In Section 2, we introduce the data source and construct the pathway-
based gene network model of hypertension. In Section 3, we analyze the statistical and topological characteristics of
the gene network. The modular structure of the network is presented in Section 4, while Section 5 presents summary
and concluding remarks.
2. Data source and network construction
The Dahl SS rat, proposed by Dahl et al. in the early 1960s [25, 26], is a widely used genetic model of human
hypertension. The consomic rat strains, used as the normotensive control for the Dahl SS rat, are generated by
substituting a chromosome or a part of a chromosome from a normal rat strain for the corresponding genomic region
of the SS rat [24, 27, 28]. Previous research has shown that substitution of chromosome 13 or 18 can attenuate
hypertension [31, 24]. Our study will focus on the hypertension-related genes listed in Ref. [24] by analysis of
biological pathways.
1 KEGG (Kyoto Encyclopedia of Genes and Genomes) website: http://www.kegg.jp/ or http://www.genome.jp/kegg/.
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Table 1: Examples of the correspondence between genes and pathways.
Gene Gene ID Pathway(s)
Timp1 116 510 rno04066
Casp6 83 584 rno04210
Ank3 361 833 rno05205
Aqp1 25 240 rno04964, rno04976
Kcnj1 24 521 rno04960, rno04971
Ctsd 171 293 rno04142, rno05152
Hist1h2ai 502 129 rno05034, rno05322
Sdc1 25 216 rno04512, rno04514, rno05144, rno05205
Col4a1 290 905 rno04151, rno04510, rno04512, rno04974, rno05146, rno05200, rno05222
Fzd2 64 512 rno04310, rno04390, rno04916, rno05166, rno05200, rno05205, rno05217
Let us consider an undirected network GH = (VH , EH), where VH = {vi} (i = 1, 2, . . . ,N) denotes the set of N
nodes, and EH = {vi, v j} the set of edges or connections between nodes. We will use the following notation: Ai j = 1
indicates that there is an edge between nodes vi and v j; and Ai j = 0 otherwise. Our pathway-based gene network
model is constructed in two steps.
Step 1. Selection of genes according to pathways
We first extract nodes from the 335 different hypertension-related genes2 given in Ref. [24] based on the KEGG
PATHWAY Database. From this Database, we can easily obtain the information of whether a gene is involved in
single or multiple pathways. Here, we only consider the pathways including hypertension-related genes, and the
genes not involved in any pathway are excluded from our study. Thus, the N = 90 hypertension-related genes, which
are involved in 157 pathways in the KEGG Database [32], are extracted to serve as nodes of the network model, where
each node represents an individual gene shown as gene symbol or CloneID. Examples of ten genes involved in one
or more pathways are shown in Table 1; here, a pathway is represented by the entry name of the Database, called the
KEGG object identifier consisting of a database-dependent prefix and a five-digit number (such as rno04066, where
the prefix “rno” designates the species to be rat).
Step 2. Establishment of connections
We now consider the correlations between any two genes according to the information of pathways. If two genes
i and j are involved in the same pathway(s), then a connection is made between such two genes (nodes):
Ai j =
{
1 if genes i and j are in the same pathway(s);
0 otherwise. (1)
Here i, j = 1, 2, . . . , 90 and i , j (note that Aii = 0 because we do not consider self-connections of nodes, i.e.,
self-interactions of genes). Consequently, there are biological regulatory relationships between genes i and j when
Ai j = 1. In such a way, we have constructed the pathway-based network of hypertension-related genes, which contains
90 nodes (genes) and 482 edges (connections), as shown in Fig. 1.
3. Statistical and topological characteristics of the gene network
In this section, we analyze the pathway-based gene network of hypertension by calculating the following indices:
degree (and average degree), degree distribution, average path length, clustering coefficient, assortativity coefficient,
and four centrality indices (degree centrality, betweenness centrality, closeness centrality and integrated centrality),
which can provide us with statistical and topological characteristics of the gene network.
3.1. Degree and degree distribution
The degree ki of a node i is the number of edges connecting to the node. The average of ki over all nodes is called
the average degree of the network, and is denoted as 〈k〉 = 1N
∑N
i=1 ki. The degree distribution function P(k) gives the
probability that a randomly selected node has exactly k edges [3, 4]. The degree distribution is one of the most basic
quantitative properties of a network.
2 All these genes are given in Table S2 (Excel file) of Supplemental Figures and Tables of Ref. [24], which can be readily accessed from the
website: http://physiolgenomics.physiology.org/content/34/1/54/suppl/DC1.
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Figure 1: Illustration of the pathway-based gene network of hypertension for the SS rat with all 90 nodes and 482 edges. The large red nodes
represent the seven hub genes. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this
article.)
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Figure 2: Degree and degree distribution of the pathway-based gene network: (left) The values of the degree of 90 nodes are shown in descending
order; (right) The degree distribution is not scale-free.
For the pathway-based gene network of hypertension, the degree ki of a node i is just the number of other genes
which are involved in the same pathway(s) as gene i. Fig. 2 plots the degree and degree distribution of the gene
network. Here, the values of the degree of 90 nodes are ranked in a descending order (with ng(k) denoting the rank
of genes in degree values), and it is found that the gene Jun of ng = 1 has the highest degree 30. The average degree
〈k〉 of this network is about 10.71. The illustration of degree distribution shows that the probability that a gene can
link with k other genes does not decay as a power-law, suggesting that the gene network does not have a scale-free
topology.
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3.2. Average path length and clustering coefficient
In a network, a path from node i to node j is a sequence of adjacent nodes starting at i and ending at j. The path
with the smallest number of edges between the two selected nodes is called the shortest path. The distance di j between
two nodes i and j is defined as the number of edges along the shortest path connecting them. The diameter D is the
maximum distance between any pair of nodes in the network, i.e., D = max{di j}. The average path length L is defined
as the mean distance between two nodes, averaged over all pairs of nodes, i.e.
L =
1
N(N − 1)
∑
i, j
di j, (2)
which offers a measure of the overall navigability of a network [33].
A clustering coefficient can be used to describe the cohesiveness of the neighborhood of a node [1, 4]. In a
network, the clustering coefficient ci is defined as the ratio between the number ei of edges that actually link the ki
neighbors of node i to each other and the total possible number of edges among them, i.e.
ci =
2ei
ki(ki − 1) (ki > 2). (3)
The clustering coefficient C of the whole network is the average of ci over all i, C = 1N
∑N
i=1 ci, which characterizes
the overall tendency of nodes to form clusters, clearly, C 6 1.
The pathway-based gene network has a very short average path length: L is about 2.331, and log(log N) < L <
log N. The diameter D is only 5 (i.e., the distance between genes Gcgr and Gnpat), which implies at most five
hops separate any two genes in the 482 connections of the network. The clustering coefficient is calculated to be
C = 0.6403, which is relatively high. Therefore, the pathway-based gene network has the small-world property (short
L and high C).
3.3. Assortativity
The concept of assortativity is introduced to describe degree correlations between neighboring nodes in a net-
work [34]. A network is assortative if high (low) degree nodes tend to be connected to other high (low) degree nodes;
otherwise, it is disassortative if high (low) degree nodes tend to be connected to other low (high) degree nodes. The
assortativity can be described by the correlation between the degrees of neighboring nodes in terms of the mean Pear-
son correlation coefficient. Let xi and yi be the degrees of the end nodes of the ith edge, with i = 1, 2, . . . , E (E is the
number of edges in the network), then the assortativity coefficient of the network is given by [34]:
r =
E−1
∑
i
xiyi −
[
E−1
∑
i
1
2 (xi + yi)
]2
E−1
∑
i
1
2 (x2i + y2i ) −
[
E−1
∑
i
1
2 (xi + yi)
]2 . (4)
The network is assortative if r > 0, and disassortative if r < 0. The assortativity coefficient of the pathway-based
gene network is calculated to be r = 0.2178, exhibiting an assortative behavior. This is different from most biological
networks which show negative r.
3.4. Centrality
3.4.1. Definitions of four centrality indices
The degree centrality Cd, betweenness centrality Cb and closeness centrality Cc are three centrality indices com-
monly used in finding out the centralization nodes of the network [35, 36]. Recently, we also introduced an integrated
centrality Cintgr to fully reflect the contribution of three centrality indices {Cd ,Cb,Cc} [23].
The degree centrality of a given node i is the proportion of other nodes that are adjacent to node i [36], i.e.
Cd(i) = kiN − 1 , (5)
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Table 2: Top 25 values of degree centrality Cd , betweenness centrality Cb, closeness centrality Cc and integrated centrality Cintgr in the pathway-
based gene network of hypertension. In this paper, nine genes are expressed as abbreviations (cf. Fig. 6 and its caption).
Gene Cd Gene Cb Gene Cc Gene Cintgr
Jun 0.3371 Sdhb 0.09327 Jun 0.5087 Jun 0.9280
Cdk4 0.3146 Jun 0.07311 Rps6kb1 0.4880 Rps6kb1 0.8359
RT1-Da 0.3034 RT1-Da 0.06903 Cycs 0.4653 Cycs 0.8156
Pdgfra 0.3034 Cycs 0.06057 Creb3l2 0.4653 Creb3l2 0.8027
Rps6kb1 0.2921 Rps6kb1 0.05791 Cdk4 0.4446 Cdk4 0.7547
Creb3l2 0.2809 Cd36 0.05748 Actg1 0.4446 Actg1 0.7281
Actg1 0.2809 Pdha1 0.04875 RT1-Da 0.4413 RT1-Da 0.7128
Csf1r 0.2697 Creb3l2 0.04067 Shc1 0.4413 Shc1 0.6662
Fn1 0.2697 Fcgr1 0.03694 Pdgfra 0.4413 Pdgfra 0.6598
Col4a1 0.2584 Ctsl 0.03632 Csf1r 0.4381 Csf1r 0.6462
Col4a2 0.2584 Cdk4 0.03088 Fn1 0.4381 Fn1 0.6390
Fzd2 0.2472 Shc1 0.02745 Cd36 0.4318 Cd36 0.6293
Cycs 0.2360 Csf1r 0.02586 Fzd2 0.4287 Fzd2 0.6206
Shc1 0.2360 Acsl1 0.02133 Col4a1 0.4227 Col4a1 0.6041
Tgfbr1 0.2360 Acsl6 0.02133 Col4a2 0.4227 Col4a2 0.5956
Fcgr1 0.2247 Pdgfra 0.01974 Tgfbr1 0.4227 Tgfbr1 0.5841
Col2a1 0.2135 Actg1 0.01955 Fcgr1 0.4197 Sdhb 0.5678
Col5a1 0.2135 Ghr 0.01847 Sdhb 0.4111 Fcgr1 0.5678
Col5a2 0.2135 Nrp1 0.01839 Mmp2 0.4083 Mmp2 0.5640
Col6a1 0.2135 Ctss 0.01467 Ctsl 0.4056 Ctsl 0.5388
Sdhb 0.2022 Cdc2a 0.01256 Col2a1 0.4056 Col2a1 0.4980
Mmp2 0.2022 Fzd2 0.01080 Col5a1 0.4056 Col5a1 0.4980
Ctsl 0.2022 Polr3e 0.01018 Col5a2 0.4056 Col5a2 0.4980
Cd36 0.1798 Col4a1 0.00987 Col6a1 0.4056 Col6a1 0.4980
Pdha1 0.1798 Col4a2 0.00987 Sdc1 0.3949 Sdc1 0.4796
here N − 1 is the maximum possible degree of the network.
The betweenness centrality of a node i is defined as the proportion of all shortest paths (geodesics) between pairs
of other nodes that include this node i [36]:
Cb(i) =
N∑
j(<k)
N∑
k
g jk(i)
g jk
, (6)
where g jk is the number of shortest paths between nodes j and k, and g jk(i) the number of shortest paths containing
node i between nodes j and k.
The closeness centrality of a node i is the number of other nodes divided by the sum of the distances between node
i and all others [35, 36]:
Cc(i) = (Li)−1 = N − 1N∑
j=1
di j
, (7)
here Li is the average distance between node i and all other nodes.
To comprehensively and quantitatively reflect the contribution of the above three centrality indices {Cd,Cb,Cc},
we can also introduce the integrated centrality Cintgr of node i, defined as follows [23]:
Cintgr(i) = 13
[
Cd(i)
Cd,max
+
Cb(i)
Cb,max
+
Cc(i)
Cc,max
]
, (8)
where Cd,max, Cb,max and Cc,max are the maximums of {Cd}, {Cb} and {Cc}, respectively. Obviously, Cintgr(i) has a value
between 0 and 1.
3.4.2. Centrality analysis and hub genes
For the pathway-based gene network of hypertension, the four centrality indices are calculated based on the above
definitions, and the top 25 values of each centrality index are listed in Table 2. In the following, we will determine
hub genes in the network through centrality analysis.
Fig. 3 describes the correspondence among degree centrality Cd , betweenness centrality Cb and closeness central-
ity Cc of nodes in the pathway-based gene network. We can see in Fig. 3 that Cc of most of the nodes is distributed
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Figure 3: Correspondence among degree centrality Cd , betweenness centrality Cb and closeness centrality Cc of nodes in the pathway-based gene
network: (left) Cd versus Cc; (right) Cb versus Cc. The red circles represent the seven hub genes. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of this article.)
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Figure 4: Three-dimensional diagram of degree centrality Cd , betweenness centrality Cb and closeness centrality Cc of nodes in the pathway-based
gene network. The red circles represent the seven hub genes. (For interpretation of the references to color in this figure legend, the reader is referred
to the web version of this article.)
in the range of (0.25, 0.51). In this range of Cc, we also observe that in Fig. 3 (left) the distribution of Cd is roughly
uniform in the range of (0.01, 0.34); while in Fig. 3 (right) Cb is non-uniformly distributed in the range of [0, 0.094),
here most of the nodes have very small Cb, and only a few nodes have large Cb which also have relatively large Cc.
Fig. 4 combines the three centrality indices {Cd,Cb,Cc} in the three-dimensional space. It can be seen from Fig. 4 that
a small number of nodes have high values of three centrality indices, which can be viewed as hubs of the network.
Generally speaking, each of these three centrality indices has its own focus on an influence of a node on other nodes
in the network, thus one can identify hubs according to that focus. However, in order to fully reflect the contribution
of all these three centrality indices, we will simply determine key hub genes using integrated centrality Cintgr, as in
Ref. [23].
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Figure 5: The values of integrated centrality Cintgr of 90 nodes in descending order for the pathway-based gene network. The red circles represent
the seven hub genes. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Table 3: Biological descriptions of seven hub genes in the pathway-based gene network.
Gene Official full name Gene ID Description
Jun jun proto-oncogene 24 516 Encodes a protein that exhibits double-stranded DNA binding
Rps6kb1 ribosomal protein S6 kinase, polypeptide 1 83 840 Encodes a protein that exhibits ATP binding; peptide binding
Cycs cytochrome c, somatic 25 309 Encodes a protein that exhibits electron carrier activity
Creb3l2 cAMP responsive element binding protein 3-like 2 362 339 Encodes a protein that exhibits cAMP response element binding
Cdk4 cyclin-dependent kinase 4 94 201 Related to circadian rhythm; organ regeneration
Actg1 actin, gamma 1 287 876 Involved in response to calcium ion
RT1-Da RT1 class II, locus Da 294 269 Involved in antigen processing
As calculated and shown above, the pathway-based gene network is not scale-free. Fig. 5 illustrates the integrated
centrality Cintgr of 90 nodes in a descending order (with ng(Cintgr) denoting the rank of genes in Cintgr) for the network,
which shows that the top seven nodes (red) have high values of Cintgr. From Table 2 and Fig. 5, seven nodes are
determined as important hub genes: Jun, Rps6kb1, Cycs, Creb3l2, Cdk4, Actg1 and RT1-Da. These seven genes
have the integrated centrality of Cintgr > 0.71, which is about 77% of its maximum (0.9280). However, it should be
mentioned that there is no strict significance threshold for Cintgr, and one can also lower the threshold to enable more
genes to be included in hub genes.
In Table 3 we list the official full names, gene IDs and biological descriptions of seven hub genes. Here, we also
provide a brief biological description of the first hub gene. The gene Jun is ranked first in Cintgr because it has the
highest Cd and Cc, as well as the second highest Cb. Jun encodes a protein that exhibits double-stranded DNA binding,
involved in aging, angiogenesis, endothelin and Rho/Rac/Cdc42 mediated signaling pathways. It is associated with
kidney neoplasms and spinal cord injuries. Recent studies have confirmed that Jun is closely related to low potassium
reaction and cell renal cell carcinoma. A low potassium diet might induce hypertension, which is always accompanied
by hypokalemia. The incidence of renal cell carcinoma coupled with hypertension is up to 14%–40% [37].
Among the seven hub genes, we note that the gene Cdk4 is the only common hub gene in both the pathway-based
gene network here and the gene co-expression network of our previous study [23]. Besides Cdk4, we also see in
Table 2 that the three genes Shc1, Fzd2 and Col4a1, which have relatively high integrated centrality Cintgr > 0.60,
are the hub genes identified in the gene co-expression network of Ref. [23]. These four genes have been confirmed
by biological and medical research to play important roles in hypertension. Moreover, we also observe that although
the gene Sdhb is ranked only joint 17th in Cintgr (= 0.5678), it has the highest betweenness centrality Cb. Since Cb
is based on the shortest paths and reflects the ability of a node to influence other related nodes in the network, Sdhb
should also be a key gene in hypertension. If we lower the threshold of integrated centrality to Cintgr > 0.50, then
these four genes (Shc1, Fzd2, Col4a1 and Sdhb) can also be included in hub genes. In this paper, we do not take this
8
Table 4: Dissimilarity scores ds(i, j) of ten nodes (genes) in the pathway-based gene network. The specific modules, which are identified after the
completion of the modular decomposition, are indicated in parentheses in the first column.
Jun RT1-Da Col4a1 Fzd2 Sdhb Gda Sec13l1 Sumo1 Aqp1 Kcnj1
Jun (I) 0.0000 0.4310 0.2931 0.2414 0.7241 0.6897 0.6034 0.5517 0.5345 0.5172
RT1-Da (I) 0.4310 0.0000 0.5172 0.3621 0.7069 0.7069 0.5517 0.5000 0.4828 0.4655
Col4a1 (I) 0.2931 0.5172 0.0000 0.2931 0.6034 0.6379 0.4828 0.4310 0.4138 0.3966
Fzd2 (I) 0.2414 0.3621 0.2931 0.0000 0.5862 0.6207 0.4655 0.4138 0.3966 0.3793
Sdhb (II) 0.7241 0.7069 0.6034 0.5862 0.0000 0.1034 0.3966 0.3448 0.3276 0.3103
Gda (II) 0.6897 0.7069 0.6379 0.6207 0.1034 0.0000 0.3276 0.2759 0.2586 0.2414
Sec13l1 (III) 0.6034 0.5517 0.4828 0.4655 0.3966 0.3276 0.0000 0.0517 0.1034 0.0862
Sumo1 (III) 0.5517 0.5000 0.4310 0.4138 0.3448 0.2759 0.0517 0.0000 0.0517 0.0345
Aqp1 (IV) 0.5345 0.4828 0.4138 0.3966 0.3276 0.2586 0.1034 0.0517 0.0000 0.0172
Kcnj1 (V) 0.5172 0.4655 0.3966 0.3793 0.3103 0.2414 0.0862 0.0345 0.0172 0.0000
lower threshold of Cintgr > 0.50 because, in view of the relatively large range of variation of Cb, we do not want the
genes of small Cb to be included in hub genes. In a wider view, however, these four genes (Shc1, Fzd2, Col4a1 and
Sdhb), together with the above seven hub genes, are worthy of further study in the future.
4. Modular structure of the gene network
Many networks are found to divide naturally into modules or communities, i.e., groups of nodes within which the
connections are relatively dense but between which they are sparser [38, 39]. In this section, we explore the modular
structure of the pathway-based gene network of hypertension.
4.1. Structural equivalence of nodes
Two nodes are structural equivalent if they have identical connections with all other nodes. We can use a dissimi-
larity index ds to measure the equivalence of two nodes i and j as follows [40]:
ds(i, j) = |V(i) + V( j)|k1 + k2 . (9)
Here i, j = 1, 2, . . . , 90, V(i) are all neighbors of node i, | · | stands for set cardinality, k1 and k2 stand for the largest and
the second largest degree in the network, respectively. Obviously, ds(i, j) has a value between 0 (completely similar)
and 1 (completely different). In Table 4 we list the dissimilarity scores of ten genes distributed in different modules
(cf. Fig. 7).
The dissimilarity scores allow us to cluster nodes in accordance with the structural equivalence into the corre-
sponding positions by the hierarchical clustering technique. First, the nodes that are most similar are grouped into a
cluster. Then, the next pair of nodes or clusters that are most similar are grouped, and this process continues until
all nodes have been joined. The dendrogram in Fig. 6 is obtained with Pajek software [40, 41], which visualizes the
above clustering process.
4.2. Modular decomposition of the network
Based on the above dendrogram, we can obtain the modular structure of the gene network, which is shown in
Fig. 7. The network consists of five modules:
(I) the largest module with 58 nodes (red and green);
(II) the second largest module with 16 nodes (blue);
(III) a small module with the highest clustering coefficient including 6 nodes (brown);
(IV) two pairs of adjacent nodes (each joined by a single connection) (purple);
(V) six isolated nodes (yellow).
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Figure 6: Dendrogram of similarities. It shows the hierarchical clustering of the pathway-based gene network. In this paper, the following nine genes
(as recorded in Ref. [24]), Rhod predicted, Polr3e predicted, Hist1h2ai predicted /// Hist1h4a predicted, Sdhb predicted, Actg1 /// LOC295810,
Col6a1 predicted, Col4a2 predicted, Prcp predicted, and Cd36 /// RGD1562323 predicted, are abbreviated as Rhod, Polr3e, Hist1h2ai, Sdhb,
Actg1, Col6a1, Col4a2, Prcp, and Cd36, respectively.
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Figure 7: Modular structure of the pathway-based gene network. Modules I–V contain 58, 16, 6, 4 and 6 nodes, respectively. The nine nodes
marked red in module I correspond to the top nine genes involved in the largest number of pathways. The seven large nodes (six red and one green)
indicate the hub genes. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Table 5: Statistical characteristics of five modules in the pathway-based gene network.
Module Nm Nm/N 〈k〉m Cm
I 58 64.44% 12.72 0.6545
II 16 17.78% 12.75 0.8917
III 6 6.67% 3 0.9000
IV 4 4.44% 1 0
V 6 6.67% 0 0
We can observe that modules I and II constitute the largest connected part of the network, containing 74 nodes and
471 edges; and the nodes are highly connected within a module but much less connected between modules.
In Table 5 we list several statistical characteristics of every module, including the number Nm of nodes, node
proportion Nm/N, average degree 〈k〉m and clustering coefficient Cm (m = I, II, III, IV,V). Here Cm is the average of
ci over all nodes in module m. From Table 5 we can see that the average degree of each of the two modules I and II
(〈k〉I = 12.72, 〈k〉II = 12.75) is greater than the average degree 〈k〉 = 10.71 of the whole network. Except modules
IV and V of CIV = CV = 0, the clustering coefficient of each of other three modules (I–III) exceeds that of the whole
network (C = 0.6403), showing that there are more connections within each of these three modules, which justifies
the modular decomposition of the whole network.
4.3. Characteristics of modular structure
The connections between nodes in the gene network are created based on whether genes are involved in the same
pathway(s). Having examined the number of pathways in which each gene is involved, we find that there are nine
genes involved in more than 10 pathways: Jun (30), RT1-Da (21), Cdk4 (17), Cycs (17), Creb3l2 (16), Actg1 (15),
Pdgfra (14), Tgfbr1 (14) and Shc1 (13), here the number of pathways involved is shown in parentheses. These nine
genes (red nodes in Fig. 7) are a basis of dense connections within the largest module I. We also note that among these
nine genes, there are six hub genes (large nodes marked red); another hub gene Rps6kb1 (large node marked green) is
involved in nine pathways.
We can examine the robustness of the network based on modular structure [39, 42]. The nodes within a module
(except IV and V in this paper) are relatively robust against mutation because there are multiple paths between any
two nodes and thus the network will not be easily broken when mutation occurs. Nevertheless, the parts of fewer
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connections between modules should be the weaknesses of the network system. Fig. 7 visualizes the weak links of
the network. The removal of these weak connections and relevant nodes would result in the breaking of the network.
Thus, the modular structure analysis can facilitate the exploration of the relationship between weak connections of the
network and drug targets of hypertension.
The genes in the largest connected part (i.e., core modules I and II) are involved in multiple pathways, and con-
tribute to a variety of biological functions. It is difficult to assign each of these genes to a single biological function
because of pleiotropy, namely, one gene might influence many different biological processes in organisms [43]. How-
ever, the genes in the small non-core module III with six nodes are involved in only two specific pathways, rno03013
(RNA transport) and rno04141 (protein processing in endoplasmic reticulum (ER)), which indicates that the non-core
module III corresponds to clearly identified pathways and functions relatively independently.
In the pathway rno03013, the different RNA species produced in the nucleus are exported through the nuclear pore
complexes (NPCs) to the cytoplasm via mobile export receptors, which is fundamental for gene expression. In the
pathway rno04141, newly synthesized peptides enter the ER via the sec61 pore and are glycosylated; correctly folded
proteins are packaged into transport vesicles and misfolded proteins are retained within the ER lumen (cf. KEGG
PATHWAY Database).
5. Summary and concluding remarks
Hypertension is a cardiovascular disease associated with long-term interaction between genetic and environmental
factors. In this study, we use pathways data to obtain backwards the relationships between the hypertension-related
genes, try to extract the complex interactions between genes through calculating statistical characteristics and analyz-
ing modular structure of the network.
The pathway-based gene network has the following characteristics: (i) The network does not obey a power-law
degree distribution and thus is not of a scale-free property. The seven hub genes that are identified by integrated
centrality Cintgr > 0.71 are: Jun, Rps6kb1, Cycs, Creb3l2, Cdk4, Actg1 and RT1-Da; they are key (feature) genes
involved in the formation of hypertension. (ii) The network shows the small-world property (i.e., a small L and a large
C), which reveals the direct influence of these hub genes on hypertension from another perspective. (iii) The network
has a modular structure. The weak connections of the network can be visualized by its modular structure, which can
help to screen out key hypertension-related genes or pathways.
In this paper, we construct the network model of hypertension-related genes based on biological pathways. Among
the seven hub genes identified in this network, only Cdk4 is also a hub gene in the gene co-expression network of our
previous study [23]. Besides Cdk4, the three genes Shc1, Fzd2 and Col4a1 with Cintgr > 0.60 in the pathway-based
gene network are identified as the hub genes in the gene co-expression network of Ref. [23]. Although we can see
that more nodes will become hub genes and thus there will be more hub genes overlapped in the both networks if we
lower the threshold of Cintgr, the hub genes in the two networks are impossible to be completely overlapped because
the two networks are constructed from the different perspectives, i.e., based on the different characters of the genes.
The results from this paper and the theoretical analysis in Ref. [23] would complement each other. The seven hub
genes in the pathway-based gene network, together with the above-mentioned Shc1, Fzd2 and Col4a1, as well as Sdhb
of the highest Cb, can be regarded as candidate genes or drug targets for further biological and medical research on
their functions; in particular, the common hub gene Cdk4 of the both networks would be worth more attention.
Moreover, the network may also be analyzed based on other functional correlation methods, such as GO analy-
sis [21], to get more molecular mechanisms about hypertension. In the next study, we will develop weighted network
models and explore the mutual regulatory relationships between genes of complex diseases using dynamical analy-
sis. These studies will provide another perspective on expounding the differentially expressed genes and finding new
drug targets for other serious diseases. Finally, we expect that the complex network approach can provide clues for
exploring the pathogenesis of critical illness from molecular perspective.
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